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Summary 20 
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Epidemiological evidence on gene-environment effect of G-protein β-3 subunit 
C825T polymorphism and sodium on blood pressure in free-living general population 
is limited. We examined the associations between C825T polymorphism and blood 
pressure levels, stratified by the sodium variables estimated by 24-h urinary sodium 
excretion and dietary questionnaire among 1,471 men and women aged 30-74 at a 
community in Japan. Our a priori hypothesis was that individuals with 825T allele 
have elevated blood pressure among subjects with high sodium intake. Among the 
whole group, systolic blood pressure level was +2.2 mmHg (p=0.10) higher in TT 
than CC genotype after adjustment for sex, age, antihypertensive medication use, body 
mass index, and alcohol consumption. Such difference was more evident among 
individuals with low sodium excretion (+4.5 mmHg, p=0.01), low present sodium 
intake (+3.2 mmHg, p=0.11), and low past sodium intake (+4.8 mmHg, p=0.02). No 
associations were observed among those with high sodium variables. Our results 
indicate that G-protein β-3 subunit C825T polymorphism is associated with higher 
systolic blood pressure levels in a large free-living Japanese population, more 
specifically in women with low sodium intake. This finding helps to explain part of 
the discrepancy of the previously reported genetic association among different ethnic 
groups. 
 
Key words: G-protein, epidemiology, salt sensitivity, gene-environment interaction, 
sodium excretion 
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INTRODUCTION 
 
G-protein activates various transmembrane receptors and intracellular signaling 
systems, and regulates arterial blood pressure (BP) (Siffert, 1998). Siffert et al. were 
the first group to describe that C825T (C-to-T substitution at nucleotide 825 in exon 
10) polymorphism of the G-protein β-3 subunit (GNB3) gene was associated with 
hypertension (Siffert et al, 1998). The same study showed that activation of pertussis 
toxin-sensitive G-proteins significantly enhanced the TC or TT genotypes of GNB3 
compared with the CC genotype.  
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Although C825T polymorphism is considered a candidate gene for 
salt-sensitive hypertension (Beeks et al, 2004), it is still uncertain whether the C825T 
polymorphism affects Na+/H+ exchanger. Furthermore, the results from subsequent 
association studies were inconsistent especially in non-Caucasians (Siffert, 2003), and 
there has been limited evidence on the gene-environmental interaction among GNB3 
C825T polymorphism, sodium and BP. 
 The aim of this study was to examine the association between GNB3 
polymorphism and BP levels according to sodium intake, estimated by 24-h urine 
collection and dietary questionnaires, in a free-living population. We thus performed a 
community-based study of 1,471 Japanese in a general community. Our a priori 
hypothesis was that individuals with 825T allele of the GNB3 gene have elevated BP 
levels in response to a high sodium intake, and thus the association between GNB3 
polymorphism and BP is more evident among individuals with a high sodium intake 
than those with a low sodium intake.  
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MATERIALS AND METHODS 
 
Subjects 
Subjects were free-living residents of a farming community of Kyowa, central Japan 
(population 17,145 by the 2000 census) aged 30-74 years, who participated in the 
2001 cardiovascular risk survey (n=2,972). Physicians explained the protocol to all 
participants, and obtained written informed consent from 95% (n=2,823) of them. In 
the present study, we included 1,471 subjects who provided a written informed 
consent, a satisfactory 24-h urine sample between 1996 and 2004, i.e. from 5 years 
prior to the 2001 cardiovascular risk surveys, and completed a salt intake 
questionnaire. The study protocol was approved by the Medical Ethics Committee of 
the University of Tsukuba. 
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Population surveys 
The population surveys were performed annually since 1981. Details of the surveys 
have been described elsewhere (Iso et al, 1996; Yamagishi et al, 2004). Well-trained 
medical technicians measured arterial systolic blood pressure (SBP) and fifth-phase 
diastolic blood pressure (DBP) using standard mercury sphygmomanometers (with 14 
cm wide and 51 cm long cuff) on the right arm of quietly seated participants after a 
period of at least 5-min rest. When SBP was ≥140 mmHg and/or DBP was ≥90 mmHg, 
the measurement was repeated; the average of two readings was used in the analysis, 
otherwise the first reading was used. The method of BP measurement was 
standardized uniformly across the surveys, and BP measurement training for our 
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medical technicians was provided before each annual survey. Hypertension was 
defined as SBP of ≥140 mmHg and/or DBP of ≥90 mmHg, and/or use of 
antihypertensive medication. The participants were asked to collect all urine over a 
24-hour period between 1996 and 2004 surveys. Subjects who provided urine samples 
of <500 ml and/or <20 hours, or those with incomplete collections based on records 
were excluded from the study. At the 2001 survey, all participants were also asked to 
complete a self-administered dietary questionnaire to estimate present and past sodium 
intake. Past sodium intake was defined as the intake before the recognition of 
hypertension for hypertensives, and approximately 10 years before the survey for 
normotensives. A sodium intake score was calculated by adding one point for each of 
10 types of sodium intake questions. Although this scoring system was validated 
previously (Iso et al, 1996; 2000; Yamagishi et al, 2004), it was tested again using the 
samples of the present study. Age and sex-adjusted mean 24-hour sodium excretion 
values across quintiles of the present sodium intake score (n=1,471) were 165, 173, 
186, 197 and 198 mmol/L (p for trend <0.001), and those of past sodium intake score 
(n=1,471) were 170, 177, 185, 187 and 202 mmol/L (p for trend <0.001). The 
Spearman correlation coefficient between past and present sodium intake scores was 
0.60 (p<0.001). Repeatability of the present and past sodium intake scores was also 
tested previously (Iso et al, 1996; Yamagishi et al, 2004) by repeating the 
questionnaire one to two years apart in a sub-sample of the population (n = 287); the 
Spearman correlation coefficient was 0.73 for the present sodium intake score 
(p<0.001), and 0.62 for the past sodium intake score (p<0.001) (Yamagishi et al, 
2004). We used age, body mass index and alcohol intake as confounding variables, 
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and sodium excretion, sodium intake as effect modifier. In the present analyses, we 
used the data of age, BP, body mass index, alcohol intake, and use of antihypertensive 
medication at the same year as 24-h urine was collected. 115 
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DNA genotyping 
GNB3 C825T genotypes were determined by the allele-specific primer-polymerase 
chain reaction method as described previously (Takarada et al, 2002; Ishiguro et al, 
2005). The designed allele-specific sense primers were 
TxR-TCTGCGGCATCACGTXCG for the 825C allele and 
FITC-TCTGCGGCATCACGTXTG for the 825T allele labeled at the 5' end either 
with fluorescein isothiocyanate (FITC) or with Texas red (TxR), and a 5’ 
biotin-end-labeled antisense primer (biotin-GAATAGTAGGCGGCCACTGA), in 
which X represents an artificial mismatch base. For high sensitivity and specificity, 
we used polymorphic base at the second site from 3’ end, and placed an artificial 
mismatch base next to the polymorphic base, instead of matched base in each primer 
(Ishiguro et al, 2005). 
 
Statistical analyses 
The analysis of covariance and chi-square test were used to compare sex-specific 
age-adjusted mean values and proportions of risk characteristics, by Tukey’s multiple 
comparison method. The chi-square test was used to examine whether the genotype 
distributions differed from that expected from Hardy-Weinberg equilibrium. The 
relation between genotype and BP levels was adjusted by age, sex, antihypertensive 
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medication use (yes or no), body mass index (BMI) and alcohol consumption, and 
examined by Dunnett’s multiple comparison method, with CC group as reference. 
Further analysis was performed stratified by the medians of urinary sodium excretion 
and sodium intake scores. For stratified analyses by the sodium intake/excretion, we 
further adjusted for the year of urine collection (1996-2000 or 2001-2004). We used 
dummy variables for adjustment of sex, antihypertensive medication and the year of 
urine collection, and continuous variables for other covariates. The interactions 
between genotype and sex, stratified sodium variables in relation to BP levels were 
examined using cross-product terms of these variables, i.e., polymorphism (CC, TC, 
TT) × sex (M or F), polymorphism × sodium intake/excretion (below or beyond the 
median value). All statistical analyses were performed using SAS version 8.02 
software (SAS Institute Inc., Cary, NC). All probability values for statistical tests were 
two-tailed, and values of p<0.05 were regarded as statistically significant.  
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RESULTS 150 
155 
160 
165 
170 
 
The frequency of GNB3 genotypes was 24.1% for the CC genotype, 49.9% for the CT 
genotype, and 25.9% for the TT genotype. The sex-specific frequencies were 23.5%, 
51.2%, and 25.3% for men, and 24.6%, 49.2%, and 26.3% for women, respectively. 
The genotype distribution was in Hardy-Weinberg equilibrium for men (p=0.92), 
women (p=0.94), and total subjects (p=1.00). The mean age of the subjects was 60 
years for men and 55 years for women. The prevalence of hypertension was 51% for 
men and 39% for women, and the respective mean values of 24-h urine sodium 
excretion were 195 mmol and 175 mmol (data not shown in the tables).  
Table 1 provides sex-specific age-adjusted characteristics according to GNB3 
genotype. The mean age of the TT group was lower for women and higher for men 
than those in other genotypes. The mean SBP and DBP were not different among the 
genotypes. Similarly, the prevalence of antihypertensive medication use and 
prevalence of hypertension were not different among the genotypes. The mean present 
sodium intake score of TT group was higher than that of CC group for women, but not 
for men. The other variables, i.e. BMI, alcohol intake, urine sodium excretion and past 
sodium intake score were not statistically different among the genotypes. 
The mean values of BP levels adjusted for sex, age, antihypertensive 
medication use, BMI, and alcohol consumption are shown for each GNB3 genotype 
(Table 2). For total subjects, the SBP levels were +2.2 mmHg higher in the TT group 
than CC group; this difference showed a trend towards significance (p=0.10).  
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When we performed further stratification by sodium variables (Table 3), the SBP 
difference between CC and TT groups was greater among subjects with lower sodium 
excretion (+4.5 mmHg, p=0.01) than among those with higher sodium excretion (+0.2 
mmHg, p=0.99), and the interaction was statistically significant (p=0.01). The 
interaction for SBP was less evident among men (p=0.58) than women (p=0.01). 
These associations were less evident for DBP.  
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The SBP difference between CC and TT genotypes was greater among subjects 
with lower present sodium intake (+3.2 mmHg, p=0.11) than those with higher 
sodium intake (+1.3 mmHg, p=0.62), although the interaction did not reach statistical 
significance (p=0.66). The associations were less evident for DBP.  
When we stratified by past sodium intake score, the SBP difference between 
CC and TT genotypes was more evident among subjects with lower past sodium 
intake (+4.8 mmHg, p=0.02) than those with higher past sodium intake (+0.2 mmHg, 
p=0.99) although the interaction did not reach statistical significance (p=0.12). Such a 
trend was not observed for DBP. 
The associations between GNB3 genotypes and BP levels became weaker when 
restricting subjects without antihypertensive medication (n=1,146); the mean SBP 
levels in the TT groups vs CC groups were 129.0 vs 127.5 mmHg (p=0.41) for total 
subjects, 131.1 vs 127.9 mmHg (p=0.15) for subjects with lower sodium excretion, 
130.8 vs 128.7 mmHg (p=0.44) for subjects with lower present sodium intake score, 
and 130.8 vs 127.2 mmHg (p=0.13) for subjects with lower past sodium intake score 
(data not shown in the tables).  
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Since second readings of BP levels were not obtained for all subjects in the 
present study, we examined data of the 2003 and 2004 surveys where two BP readings 
were obtained (n=1,347). The results, however, did not alter materially when we used 
the average of the two readings of BP; the mean SBP levels in the TT groups vs CC 
groups were 132.8 vs 131.2 mmHg (p=0.37) for total subjects, 136.0 vs 131.8 mmHg 
(p=0.047) for subjects with lower sodium excretion, 134.3 vs 131.7 mmHg (p=0.29) 
for subjects with lower present sodium intake score, and 132.7 vs 129.2 mmHg 
(p=0.15) for subjects with lower past sodium intake score (data not shown in the 
tables). 
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The mean BP levels were higher in subjects on medication use than those 
without medication; age-adjusted mean SBPs were 139.9 mmHg in those with 
medication vs 129.0 mmHg in those without medication (p<0.0001), and respective 
DBP were 81.9 mmHg vs 77.8 mmHg (p<0.0001) (data not shown in the tables). The 
distribution of genotypes was similar between subjects with and without 
antihypertensive medication; the distributions of CC, CT and TT genotype were 26%, 
51% and 22% for subjects with medication, and 23%, 50%, and 27% for subjects 
without medication (p for chi-square test = 0.19). 
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DISCUSSION 
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In a previous study, we showed that high sodium intake strengthened the gene-blood 
pressure associations for angiotensinogen (AGT) T174M (Yamagishi et al, 2004) and 
α-adducin (ADD1) G460W polymorphisms (Yamagishi et al, 2004). In contrast, in the 
present study, the GNB3-systolic blood pressure association was more evident among 
subjects with lower sodium intake/excretion, but not with higher intake/excretion. 
This result was unexpected, but it is possible that high salt intake masks the potential 
effect of GNB3 on blood pressure levels. Our finding helps to explain the 
inconsistency of the reported genetic associations: positive associations in the majority 
of studies in whites (Siffert, 2003), but no associations in the majority of studies of 
Japanese (Kato et al, 1998; Kario et al, 1999; Ishikawa et al, 2000; Tozawa, 2001; 
Suwazono et al, 2004; Shioji et al, 2004), African-American (Larson et al ,2000), 
Chinese (Huang et al , 2003; Li et al, 2005), Taiwanese (Tsai et al, 2000), and Kazakh 
in China (Wang et al, 2004). This ethnic difference may be explained in part by 
differences in salt intake, which is higher in Asian and African-American populations 
than in whites (Intersalt Cooperative Research Group, 1988).  
The GNB3 C825T polymorphism has been suspected to be a genetic marker of 
salt-sensitive hypertension (Beeks et al, 2004). Siffert et al. reported significantly 
enhanced activation of pertussis toxin-sensitive G proteins in TC and TT genotypes of 
GNB3 relative to the CC genotype, which implied that GNB3 might affect Na+/H+ 
exchanger (Siffert et al, 1998). Other studies showed significant relations among 
GNB3 genotype and low plasma renin activity (Schunkert et al, 1998), high response 
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to diuretics (Turner et al, 2001), left ventricular hypertrophy (Poch et al, 2000; 
Semplicini et al, 2001) and renal plasma flow (Zeltner et al, 2001), which support the 
above hypothesis. However, it is still uncertain whether the C825T polymorphism 
affects Na+/H+ exchanger since two experimental studies showed no association 
between C825T polymorphism and salt-sensitivity (Schorr et al, 2000; 
Pamies-Andreu et al, 2003). Also in the present study, sodium did not strengthen the 
associations of GNB3 with BP levels, which is in contradiction to our a priori 
hypothesis.  
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In the present study, approximately 20% of the participating individuals used 
antihypertensive medication, which may have obscured the genetic effect of BP levels. 
When we excluded individuals with antihypertensive medication from the analysis, 
the gene-BP association became weaker. Weakening of the association may be caused 
by the smaller variation of BP levels after the exclusion of subjects with high BP 
levels. In fact, the mean BP levels were higher in subjects on medication use than 
those without medication.  
 The strength of the present study was that we used a large community-based 
free-living population. In addition, we obtained 24-h urine collection samples and 
sodium intake scores, which allowed us to test gene-environmental interactions of the 
GNB3 C825T genotype with BP levels in a general population. Previously, two 
experimental studies with smaller numbers of subjects (Schorr et al, 2000; 
Pamies-Andreu et al, 2003) examined the relation between C825T genotype and 
dietary salt or salt sensitivity, with negative results. However, to our knowledge, the 
Yamagishi et al., Page 13  
present study is the first report that evaluated the gene-environmental interaction of 
GNB3 polymorphism, sodium, and BP in a large free-living general population. 260 
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 The limitations of the present study warrant discussion. Firstly, we did not have 
information about the antihypertensive agents used by the population tested. The use 
of hydrochlorothiazide or clonidine was reported to reduce SBP levels more in 
subjects with TT genotype than in those with CC genotype (Turner et al, 2001; 
Nürnberger et al, 2003). However, in this community, it is our impression that the 
majority of hypertensive patients were treated primarily by calcium channel blockers, 
like in other communities of Japan. Long-term use of calcium blockers is unlikely to 
change sodium excretion or sodium retention (Leonetti, 1994). Secondly, the gene-BP 
association was primarily obtained for women only, although the interaction of sex in 
relation to the genotype with BP levels was not statistically significant (p for 
sex-interaction = 0.94 for SBP). A probable reason for the relatively weak association 
in men was the smaller number of men than women. Thirdly, the variation of sodium 
excretion by one 24-h urine sample may be very large and the possibility of 
misclassification between low and high sodium excretion groups could be real. 
However, since the study included a large sample size, the impact of misclassification 
across the stratification is probably small. In the present study, 66% of persons 
remained in the same group of higher or lower sodium intake after one-year 
re-collection of urinary sodium excretion in the sub-sample group. Lastly, in Table 3, 
blood pressure levels were sometimes lower in groups with higher sodium excretion 
or intake than lower ones with the same genotypes, which was also observed in 
Japanese populations according to the Intersalt study (Intersalt Cooperative Research 
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Group, 1988). A plausible reason for this phenomenon is that most of the 
hypertensives attempted to reduce salt intake when they recognized their blood 
pressure levels were high, since salt reduction is well known to reduce blood pressure 
in the Japanese society.  285 
290 
 In conclusion, the GNB3 C825T polymorphism tends to be associated with 
SBP levels in Japanese population. This association was more specifically observed 
among women with a low sodium excretion against our a priori hypothesis. This 
finding, however, helps to explain part of the discrepancy of the reported genetic 
association among different ethnic groups.
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Table 1. Age-adjusted characteristics according to G-protein β-3 subunit C825T genotype, men and women aged 30-74 years. 
 Women Men Total 
 CC CT TT CC CT TT CC CT TT 
Number 218 436 233 137 299 148 355 735 381 
Age, year 56.4 55.6 53.6** ‡ 59.1 59.9 61.7* 57.4 57.4 56.7 
Systolic blood pressure, mmHg 128.6 128.8 130.8 133.8 134.2 136.3 130.8 131.0 132.7
Diastolic blood pressure, mmHg 76.0 77.3 77.7 81.0 80.9 82.1 78.1 78.8 79.3 
Use of antihypertensive medication, % 21.9 21.7 17.4 26.2 23.7 23.9 23.9 22.5 19.6 
Hypertension, %† 39.0 39.2 37.3 52.5 50.1 50.8 44.7 43.7 42.1 
Body mass index, kg/m2 23.4 23.1 23.5 23.5 23.8 23.7 23.5 23.4 23.5 
Alcohol intake, g/day 1.0 1.3 2.2 18.6 20.9 18.9 7.8 9.3 8.7 
Urine sodium excretion, mmol 172.3 176.4 178.4 182.0 199.2 199.1 176.1 185.7 186.4
Present sodium intake score 4.3 4.5 4.8* 5.6 5.4 5.4 4.8 4.8 5.0 
Past sodium intake score 5.7 5.8 6.0 6.8 6.7 6.6 6.1 6.1 6.2 
 
†Hypertension was defined as systolic blood pressure of ≥ 140 mmHg and/or diastolic blood pressure of ≥ 90 mmHg and/or use of 
antihypertensive medication. 
405 
* p<0.05 and ** p<0.01 compared with CC genotype, ‡ p<0.05 compared with CT genotype (Tukey's multiple comparison method). 
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Table 2. Blood pressure levels according to G-protein β-3 subunit C825Tgenotype, men and women aged 30-74 years. 
 410 
 CC CT TT p for difference of CC vs TT 
Total 355 735 381  
  Systolic blood pressure, mmHg 130.7 131.0 132.9 0.10 
  Diastolic blood pressure, mmHg 78.1 78.8 79.3 0.18 
Men 137 299 148  
  Systolic blood pressure, mmHg 134.1 134.0 136.5 0.29 
  Diastolic blood pressure, mmHg 81.2 80.8 82.1 0.62 
Women 218 436 233  
  Systolic blood pressure, mmHg 128.3 129.0 130.8 0.18 
  Diastolic blood pressure, mmHg 75.9 77.4 77.6 0.15 
 
Blood pressure values were adjusted for sex, age, antihypertensive medication use, body mass index and alcohol consumption. 
Tests for difference from CC genotype were conducted using Dunnett's multiple comparison method. 
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415 Table 3. Blood pressure levels according to GNB3 C825T genotype, stratified by sodium excretion/intake, men and women aged 30-74 years. 
 Women Men Total 
  
CC CT TT 
p for 
difference of 
CC vs TT 
CC CT TT 
p for 
difference of 
CC vs TT 
CC CT TT 
p for 
difference of 
CC vs TT 
Stratified by urinary sodium excretion             
 Below median 113 218 112  76 144 72  189 362 184  
  Systolic blood pressure, mmHg 129.1 129.1 135.0 0.01 134.0 132.6 136.4 0.54 131.0 130.5 135.5 0.01 
  Diastolic blood pressure, mmHg 76.1 77.1 79.1 0.06 81.8 80.1 81.6 0.99 78.3 78.3 80.1 0.17 
 Median or more 105 218 121  61 155 76  166 373 197  
  Systolic blood pressure, mmHg 127.5 128.8 126.9 0.93 134.3 135.3 136.5 0.55 130.3 131.4 130.5 0.99 
  Diastolic blood pressure, mmHg 75.7 77.8 76.1 0.95 80.4 81.4 82.6 0.28 77.7 79.2 78.5 0.61 
Stratified by present sodium intake score            
 Below median 109 229 104  65 146 78  174 375 182  
  Systolic blood pressure, mmHg 129.6 130.5 133.0 0.23 135.4 136.8 138.3 0.39 131.9 132.9 135.1 0.11 
  Diastolic blood pressure, mmHg 75.6 78.1 78.1 0.13 82.0 81.2 83.2 0.67 78.1 79.4 80.0 0.13 
 Median or more 109 207 129  72 153 70  181 360 199  
  Systolic blood pressure, mmHg 126.8 127.6 128.7 0.54 132.5 131.5 134.6 0.60 129.5 129.0 130.8 0.62 
  Diastolic blood pressure, mmHg 76.2 76.7 77.1 0.73 80.5 80.3 81.0 0.92 78.1 78.1 78.6 0.84 
Stratified by past sodium intake score             
 Below median 95 188 96  60 129 68  155 317 164  
  Systolic blood pressure, mmHg 126.9 128.3 132.2 0.05 133.3 136.0 137.6 0.23 129.5 131.5 134.3 0.02 
  Diastolic blood pressure, mmHg 75.6 76.8 77.6 0.32 82.7 81.3 83.3 0.91 78.5 78.7 79.8 0.42 
 Median or more 123 248 137  77 170 80  200 418 217  
  Systolic blood pressure, mmHg 129.5 129.3 130.0 0.95 135.0 132.4 135.3 0.99 131.7 130.5 131.9 0.99 
  Diastolic blood pressure, mmHg 76.2 77.8 77.6 0.41 80.4 80.3 81.2 0.82 77.9 78.8 79.0 0.44 
Blood pressure was adjusted for sex, age, antihypertensive medication use, body mass index, alcohol consumption and year of urine collection. Tests for difference from CC genotype were 
conducted using Dunnett's multiple comparison method. Median values of urinary sodium excretion are 169.9 mmol/day for women and 185.2 mmol/day for men, 5 for present sodium intake 
score in women and 6 in men, and 6 for past sodium intake score in women and 7 in men. 
